08.19.2026
Prevent & Delay
$300,000.00
12 months
Preparing for a Phase 1 clinical trial of antigenic-specific engineered Treg therapy to treat T1D
The funds will support activities related to the development of an engineered Treg therapy for the treatment of type 1 diabetes.